193 related articles for article (PubMed ID: 30022832)
1. A meta-analysis and systematic review evaluating the use of erythropoietin in total hip and knee arthroplasty.
Li Y; Yin P; Lv H; Meng Y; Zhang L; Tang P
Ther Clin Risk Manag; 2018; 14():1191-1204. PubMed ID: 30022832
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness and safety of preoperative use of erythropoietin in patients scheduled for total hip or knee arthroplasty: A systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Jiang C; Peng H; Feng B; Li Y; Weng X
Medicine (Baltimore); 2016 Jul; 95(27):e4122. PubMed ID: 27399121
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty.
Voorn VM; van der Hout A; So-Osman C; Vliet Vlieland TP; Nelissen RG; van den Akker-van Marle ME; Dahan A; Marang-van de Mheen PJ; van Bodegom-Vos L
Vox Sang; 2016 Oct; 111(3):219-225. PubMed ID: 27314459
[TBL] [Abstract][Full Text] [Related]
4. Preoperative erythropoietin alpha reduces postoperative transfusions in THA and TKA but may not be cost-effective.
Bedair H; Yang J; Dwyer MK; McCarthy JC
Clin Orthop Relat Res; 2015 Feb; 473(2):590-6. PubMed ID: 25106796
[TBL] [Abstract][Full Text] [Related]
5. The reduction of preoperative autologous blood donation for primary total hip or knee arthroplasty: the effect on subsequent transfusion rates.
Couvret C; Tricoche S; Baud A; Dabo B; Buchet S; Palud M; Fusciardi J
Anesth Analg; 2002 Apr; 94(4):815-23, table of contents. PubMed ID: 11916778
[TBL] [Abstract][Full Text] [Related]
6. A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty.
Couvret C; Laffon M; Baud A; Payen V; Burdin P; Fusciardi J
Anesth Analg; 2004 Jul; 99(1):262-271. PubMed ID: 15281542
[TBL] [Abstract][Full Text] [Related]
7. The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials.
Alsaleh K; Alotaibi GS; Almodaimegh HS; Aleem AA; Kouroukis CT
J Arthroplasty; 2013 Oct; 28(9):1463-72. PubMed ID: 23528548
[TBL] [Abstract][Full Text] [Related]
8. Preoperative erythropoietin within a patient blood management program decreases both blood transfusion and postoperative anemia: a prospective observational study.
Biboulet P; Motais C; Pencole M; Karam O; Dangelser G; Smilevitch P; Maissiat G; Capdevila X; Bringuier S
Transfusion; 2020 Aug; 60(8):1732-1740. PubMed ID: 32681743
[TBL] [Abstract][Full Text] [Related]
9. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
Green WS; Toy P; Bozic KJ
J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.
Sun Q; Li J; Chen J; Zheng C; Liu C; Jia Y
BMJ Open; 2019 Jan; 9(1):e024350. PubMed ID: 30696680
[TBL] [Abstract][Full Text] [Related]
11. Preoperative use of recombinant human erythropoietin before total joint arthroplasty.
Bezwada HP; Nazarian DG; Henry DH; Booth RE
J Bone Joint Surg Am; 2003 Sep; 85(9):1795-800. PubMed ID: 12954840
[TBL] [Abstract][Full Text] [Related]
12. Does subcutaneous administration of recombinant human erythropoietin increase thrombotic events in total hip arthroplasty? A prospective thrombelastography analysis.
Ruan RX; Bai CW; Zhang L; Huang CR; Pan S; Zhang XC; Zhu ZY; Zheng X; Guo KJ
J Orthop Surg Res; 2020 Nov; 15(1):546. PubMed ID: 33213494
[TBL] [Abstract][Full Text] [Related]
13. Use of preoperative erythropoietin therapy to facilitate autologous blood donation in orthopedic surgery: A meta-analysis.
Chang X; Li Q; Tang H
Medicine (Baltimore); 2020 Jan; 99(2):e18577. PubMed ID: 31914036
[TBL] [Abstract][Full Text] [Related]
14. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty.
Newman ET; Watters TS; Lewis JS; Jennings JM; Wellman SS; Attarian DE; Grant SA; Green CL; Vail TP; Bolognesi MP
J Bone Joint Surg Am; 2014 Feb; 96(4):279-84. PubMed ID: 24553883
[TBL] [Abstract][Full Text] [Related]
15. Effect of Erythropoietin on Transfusion Requirements for Craniosynostosis Surgery in Children.
Aljaaly HA; Aldekhayel SA; Diaz-Abele J; Karunanayka M; Gilardino MS
J Craniofac Surg; 2017 Jul; 28(5):1315-1319. PubMed ID: 28582302
[TBL] [Abstract][Full Text] [Related]
16. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery.
Cuenca J; García-Erce JA; Martínez F; Pérez-Serrano L; Herrera A; Muñoz M
Transfusion; 2006 Jul; 46(7):1112-9. PubMed ID: 16836557
[TBL] [Abstract][Full Text] [Related]
17. Effect of erythropoietin on perioperative blood transfusions in primary total hip arthroplasty: A systematic review.
Abram D; Tran MH
Transfus Apher Sci; 2023 Aug; 62(4):103718. PubMed ID: 37173207
[TBL] [Abstract][Full Text] [Related]
18. Predictors of perioperative blood loss in total joint arthroplasty.
Park JH; Rasouli MR; Mortazavi SM; Tokarski AT; Maltenfort MG; Parvizi J
J Bone Joint Surg Am; 2013 Oct; 95(19):1777-83. PubMed ID: 24088970
[TBL] [Abstract][Full Text] [Related]
19. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
[TBL] [Abstract][Full Text] [Related]
20. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty.
Stowell CP; Chandler H; Jové M; Guilfoyle M; Wacholtz MC
Orthopedics; 1999 Jan; 22(1 Suppl):s105-12. PubMed ID: 9927110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
